affiniatx.comHealthcareFounded: 2019Funding to Date: $179.09MM
Affinia Therapeutics’ purpose is to develop gene therapies that can have a transformative impact on people affected by devastating rare and non-rare diseases and methodically engineers novel AAV vectors and regulatory elements to make gene therapies with potentially improved tissue tropism, cell specificity, safety, and yields.
View Enterprise Value for Affinia Therapeutics.